Skip to main content
. 2019 Jul 3;10:737. doi: 10.3389/fphar.2019.00737

Figure 3.

Figure 3

Bioinformatics analyses for screening the key bioactive compound and predicting its target and signaling pathway. (A) The PPI analysis of the phosphorylated proteins related to the key node and function. (B) Molecular docking of PEI with EGFR; PyMOL software was used to display the 3D map of the interaction of PEI with EGFR (PDB:3W2S). (C) The bioinformatics pathway analysis was used to predict that the bioactive ingredient PEI acted on the EGFR signaling pathway.